05.01.2013 Views

Depletion of eosinophils in mice through the use - Journal of ...

Depletion of eosinophils in mice through the use - Journal of ...

Depletion of eosinophils in mice through the use - Journal of ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Fig. 5. Flow cytometry <strong>of</strong> N. brasiliensis (Nb) -<strong>in</strong>fected and -un<strong>in</strong>fected mo<strong>use</strong><br />

BAL sta<strong>in</strong>ed with FITC 6SH2-59. (A) Un<strong>in</strong>fected BALB/c, (B) Nb-<strong>in</strong>fected<br />

BALB/c, (C) May-Grünwald Giemsa-sta<strong>in</strong>ed, unsorted Nb-<strong>in</strong>fected BAL, (D)<br />

FACS-sorted CCR3-positive Nb-<strong>in</strong>fected BAL. The CCR3-positive sta<strong>in</strong><strong>in</strong>g<br />

cells represents a pure population <strong>of</strong> <strong>eos<strong>in</strong>ophils</strong>.<br />

polarized Th1 and Th2 populations, CD4 � and CD8 � T cells,<br />

and Y3 showed no appreciable CCR3 message, however, <strong>the</strong><br />

Y3/mCCR3-transfected cell l<strong>in</strong>e produced an easily detectable<br />

band (Fig. 6A). In a separate Nor<strong>the</strong>rn experiment, CCR3<br />

mRNA was not detected <strong>in</strong> rest<strong>in</strong>g or activated 3� polarized<br />

Th1 or Th2 cells. As a more sensitive assay <strong>of</strong> CCR3 mRNA, a<br />

quantitative RT-PCR analysis was performed with samples <strong>of</strong><br />

some <strong>of</strong> <strong>the</strong> same mRNA preparations <strong>use</strong>d <strong>in</strong> <strong>the</strong> Nor<strong>the</strong>rn blot<br />

analysis. RNA from activated Th2 cells did <strong>in</strong>deed conta<strong>in</strong><br />

CCR3 mRNA, but <strong>the</strong> amounts were approximately 80-fold less<br />

than <strong>in</strong> a comparable sample from <strong>the</strong> Y3/mCCR3-transfected<br />

l<strong>in</strong>e (Fig. 6B). If CCR3 were expressed on <strong>the</strong>se two cells <strong>in</strong> a<br />

ratio similar to <strong>the</strong>ir mRNA content, it would be quite<br />

consistent with <strong>the</strong> differences <strong>in</strong> fluorescent sta<strong>in</strong><strong>in</strong>g and<br />

functional responses between <strong>the</strong>se two cell populations. In a<br />

separate RT-PCR analysis, us<strong>in</strong>g a higher cycle number, both<br />

nonactivated Th2 and activated Th1 populations appeared to<br />

express approximately 50-fold lower levels <strong>of</strong> CCR3 mRNA<br />

than did activated Th2 cells (Fig. 6C). This result could<br />

represent lower levels <strong>of</strong> CCR3 mRNA expression by all cells or<br />

<strong>the</strong> presence <strong>of</strong> a small number <strong>of</strong> activated Th2 cells <strong>in</strong> <strong>the</strong>se<br />

populations. As a control, PCR analysis <strong>of</strong> parallel samples <strong>of</strong><br />

all mRNAs without reverse transcription did not show <strong>the</strong><br />

CCR3 band, demonstrat<strong>in</strong>g that contam<strong>in</strong>at<strong>in</strong>g genomic DNA<br />

was not be<strong>in</strong>g detected <strong>in</strong> <strong>the</strong>se PCR assays. Whe<strong>the</strong>r <strong>the</strong> low<br />

level <strong>of</strong> expression <strong>of</strong> CCR3 mRNA reflects a similar low level<br />

<strong>of</strong> surface CCR3 expression on <strong>the</strong>se cells is not yet known, but<br />

<strong>the</strong>se data make clear that, <strong>in</strong> <strong>the</strong> mo<strong>use</strong>, CCR3 expression is<br />

not a <strong>use</strong>ful basis for dist<strong>in</strong>guish<strong>in</strong>g Th2 cells from o<strong>the</strong>r T<br />

cells.<br />

Some anti-mCCR3 mAbs can specifically deplete<br />

<strong>eos<strong>in</strong>ophils</strong> <strong>in</strong> vivo<br />

Three anti-CCR3 mAbs were chosen for <strong>in</strong> vivo studies:<br />

6SH2-59 (IgG2a), 6SH2-88 (IgG2b), and 6S2-19-4(IgG2b).<br />

IgG2b is <strong>the</strong> most efficient complement-fix<strong>in</strong>g rat IgG subclass<br />

and it had been previously demonstrated that <strong>the</strong> rat IgG2b<br />

anti-mo<strong>use</strong> Ly-6G antibody, RB6-8C5, could be <strong>use</strong>d to<br />

specifically deplete <strong>eos<strong>in</strong>ophils</strong> and neutrophils <strong>in</strong> vivo [25]. To<br />

test whe<strong>the</strong>r anti-CCR3 mAbs <strong>of</strong> <strong>the</strong> IgG2b subclass could be<br />

<strong>use</strong>d to specifically deplete <strong>eos<strong>in</strong>ophils</strong> <strong>in</strong> a similar manner, N.<br />

brasiliensis-<strong>in</strong>fected <strong>mice</strong> were <strong>in</strong>jected with 0.5 mg <strong>of</strong> 6S2-<br />

19-4 or 6SH2-88. For comparison, o<strong>the</strong>r groups were <strong>in</strong>jected<br />

with <strong>the</strong> IgG2a anti-CCR3 mAb 6SH2-59 or <strong>the</strong> IgG2b<br />

anti-Ly-6G mAb, RB6-8C5. Blood <strong>eos<strong>in</strong>ophils</strong> were counted<br />

before and after adm<strong>in</strong>istration <strong>of</strong> <strong>the</strong> mAbs. Both <strong>of</strong> <strong>the</strong> IgG2b<br />

anti-CCR3 mAbs, 6S2-19-4 and 6SH2-88, depleted <strong>the</strong> circulat<strong>in</strong>g<br />

<strong>eos<strong>in</strong>ophils</strong> to below <strong>the</strong> levels <strong>of</strong> un<strong>in</strong>fected <strong>mice</strong> with<strong>in</strong><br />

24 h and <strong>the</strong>se levels rema<strong>in</strong>ed low for at least 7 days (Table 1).<br />

In subsequent experiments, as little as 100 µg <strong>of</strong> ei<strong>the</strong>r mAb<br />

gave maximal depletion <strong>of</strong> <strong>eos<strong>in</strong>ophils</strong> at <strong>the</strong> 24 h time po<strong>in</strong>t. In<br />

contrast, no significant depletion was observed with <strong>the</strong> IgG2a<br />

anti-CCR3 mAb 6SH2-59. Differential blood smears showed<br />

that <strong>the</strong> IgG2b anti-CCR3 mAbs depleted <strong>eos<strong>in</strong>ophils</strong>, but not<br />

neutrophils (data not shown), whereas <strong>the</strong> RB6-8C5 mAb<br />

depleted both cell types [25].<br />

Repeated anti-mCCR3 mAb treatment can<br />

partially deplete <strong>eos<strong>in</strong>ophils</strong> <strong>in</strong> N. brasiliensis<strong>in</strong>fected<br />

lung tissue and BAL fluid<br />

In <strong>the</strong> experiments discussed above, relatively little eos<strong>in</strong>ophil<br />

depletion was observed <strong>in</strong> <strong>the</strong> lung <strong>in</strong>filtrates or BAL <strong>of</strong> <strong>mice</strong><br />

given a s<strong>in</strong>gle <strong>in</strong>jection <strong>of</strong> anti-CCR3 mAb. To determ<strong>in</strong>e<br />

whe<strong>the</strong>r depletion <strong>in</strong> <strong>the</strong>se compartments would be more<br />

effective if begun at <strong>the</strong> <strong>in</strong>itiation <strong>of</strong> <strong>the</strong> <strong>in</strong>fection, <strong>mice</strong> were<br />

given 0.5 mg <strong>of</strong> 6S2-19-4 <strong>in</strong>traperitoneally 2 days before N.<br />

brasiliensis <strong>in</strong>fection and <strong>the</strong>n aga<strong>in</strong> on days 3, 8, and 11. Mice<br />

were killed on day 12 and <strong>the</strong> lungs, BAL fluid, and blood were<br />

collected for analysis. As expected, anti-CCR3 mAb-treated<br />

animals had low circulat<strong>in</strong>g eos<strong>in</strong>ophil levels comparable to<br />

un<strong>in</strong>fected control <strong>mice</strong> (data not shown). Total eos<strong>in</strong>ophil<br />

numbers <strong>in</strong> BAL fluid, as assessed by differential cell counts,<br />

were reduced from 3.55 � 10 6 � 1.42 � 10 6 <strong>in</strong> N. brasiliensis<strong>in</strong>fected<br />

<strong>mice</strong> to 1.07 � 10 6 � 0.46 � 10 6 <strong>in</strong> <strong>in</strong>fected,<br />

anti-CCR3-treated <strong>mice</strong> (n � 6 <strong>in</strong> each group). Anti-CCR3<br />

mAb treatment did not appear to deplete any cell type o<strong>the</strong>r<br />

than <strong>eos<strong>in</strong>ophils</strong> <strong>in</strong> ei<strong>the</strong>r blood or BAL cells. Paraff<strong>in</strong> sections<br />

<strong>of</strong> <strong>the</strong> lungs taken from animals treated with 6S2-19-4 showed a<br />

similar significant reduction <strong>in</strong> <strong>eos<strong>in</strong>ophils</strong>, <strong>in</strong> this case, to<br />

approximately 50% <strong>of</strong> that <strong>in</strong> <strong>in</strong>fected controls (data not shown).<br />

Thus <strong>the</strong> eos<strong>in</strong>ophil population <strong>in</strong> <strong>the</strong> lung tissue and BAL were<br />

partially protected from antibody-mediated kill<strong>in</strong>g. One possible<br />

explanation is that <strong>the</strong> expression <strong>of</strong> CCR3 on many<br />

Grimaldi et al. <strong>Depletion</strong> <strong>of</strong> mo<strong>use</strong> <strong>eos<strong>in</strong>ophils</strong> <strong>through</strong> <strong>the</strong> <strong>use</strong> <strong>of</strong> antibodies 851

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!